Genestra AFA-gen capsules recalled for high microcystins levels
Seroyal International recalls Genestra AFA-gen capsules due to microcystins exceeding safety limits. Consumers should check product details and contact for guidance.
Recall notice
Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification.
Contact the company
What happened, in plain English
Seroyal International is recalling Genestra AFA-gen capsules because they contain microcystins levels above the safety limit. This could pose a health risk if consumed. Read more at govinfonow.com/recall/18797-genestra-afa-gen-capsules-recalled-for-high-microcystins-levels.
Source Summary by GovInfoNow · govinfonow.com/recall/18797-genestra-afa-gen-capsules-recalled-for-high-microcystins-levels · Updated October 6, 2026 · FDA enforcement record: FDA #F-1756-2018
Cite this page
“Genestra AFA-gen capsules recalled for high microcystins levels.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/18797-genestra-afa-gen-capsules-recalled-for-high-microcystins-levels. Based on FDA recall #F-1756-2018 (https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-1756-2018%22&limit=1).
Why it’s dangerous
The capsules contain microcystins levels that exceed the specified safety limit. Microcystins are toxins that can be harmful if ingested in high amounts, potentially causing health issues.
Who’s affected
People who purchased the Genestra AFA-gen capsules with lot number 6E436-0 between 2018 and the expiry date of 09/2018 are affected. Those using the product for dietary supplements are most at risk.
How to tell if you have this one
Check for the product code #07596 and lot number 6E436-0 on the bottle. The capsules come in a white 150cc HDPE bottle with a desiccant and white cap, packaged in 12 bottles per case.
- Brand
Seroyal International- Category
Food
What to do — step by step
Check Product Details
Look for product code #07596 and lot number 6E436-0 on the bottle.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “Product was distributed throughout the United States and Canada (see attached document for list of Canadian consignees).” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 2.3 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest food recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #F-1756-2018 (July 27, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for F-1756-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.